• These Analysts Think Auxly Cannabis Group Inc.’s (CVE:XLY) Sales Are Under Threat

    These Analysts Think Auxly Cannabis Group Inc.'s (CVE:XLY) Sales Are Under ThreatOne thing we could say about the analysts on Auxly Cannabis Group Inc. (CVE:XLY) – they aren't optimistic, having just…

    from Yahoo Finance https://ift.tt/2MCkhKE

  • 3 exciting small cap ASX shares to watch very closely

    portrait of woman holding popcorn watching a movie

    Right now, I believe that are a number of small cap ASX shares that have the potential to grow into much larger entities in the future.

    Three small cap shares which I feel would be worth keeping a close eye on are listed below. Here’s why I like them:

    Alcidion Group Ltd (ASX: ALC)

    The first small cap ASX share to watch is Alcidion. It is a healthcare informatics solutions company which provides software that improves the efficacy and cost of delivering services to patients. Its software also helps to reduce hospital-acquired complications, which can ultimately save lives. I believe Alcidion is well-positioned for growth thanks to the trend for healthcare organisations to shift to a paperless environment. And while the pandemic could stifle its near term growth, I remain confident in its long term outlook.

    Medadvisor Ltd (ASX: MDR)

    A second small cap ASX share to watch is Medadvisor. It is a healthcare technology company which is focused on personal medication adherence. Medadvisor’s app connects to pharmacy dispensing systems to automatically retrieve medication records and drive an intelligent training, information, and reminder system. This has been designed to ensure correct and reliable medication use. Another product which I feel has a lot of potential is its telehealth solution. This allows patients to attend GP consultations from the comfort of their own home.

    Serko Ltd (ASX: SKO)

    A final small cap share to watch is Serko. It is a technology company focused on corporate travel and expense management. It was growing at a very strong rate prior to the pandemic. This was driven partly by the increasing demand for its Zeno product. Zeno revolutionises the world of online travel booking technology and expense management. Demand for its services will inevitably be impacted by the current crisis, but I expect it to bounce back strongly once conditions ease.

    And here are more top shares to consider. All five recommendations below look very cheap right now…

    NEW! 5 Cheap Stocks With Massive Upside Potential

    Our experts at The Motley Fool have just released a FREE report detailing 5 shares you can buy now to take advantage of the much cheaper share prices on offer.

    One is a diversified conglomerate trading over 30% off it’s all-time high, all while offering a fully franked dividend yield of over 3%…

    Another is a former stock market darling that is one of Australia’s most popular and iconic businesses. Trading at a significant discount to its 52-week high, not only does this stock offer massive upside potential, but it also trades on an attractive fully franked dividend yield of almost 4%.

    Plus, this free report highlights 3 more cheap bets that could position you to profit in 2020 and beyond.

    Simply click here to scoop up your FREE copy and discover the names of all 5 cheap shares.

    But you will have to hurry because the cheap share prices on offer today might not last for long.

    As of 2/6/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd, MedAdvisor, and Serko Ltd. The Motley Fool Australia has recommended Alcidion Group Ltd, MedAdvisor, and Serko Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 3 exciting small cap ASX shares to watch very closely appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/2UhBJbO

  • You Haven’t (Yet) Missed the Nio Opportunity

    You Haven’t (Yet) Missed the Nio OpportunityIt's natural to wish that you had taken a stake in Nio (NYSE:NIO) when Nio stock was trading at $2 and change this year. That's a phenomenon you could call "hindsight investing," where a great stock trade is obvious only after the fact.Source: Sundry Photography / Shutterstock.com Nio stock is higher than $2 now, of course, and that raises the question of whether it can go much higher. Should value-focused investors avoid a particular stock just because it recently doubled in value? The thoroughly unsatisfying answer is: it depends on the stock and the circumstances.Based on the data, there should be plenty of upside left for Nio stock. In fact, it's entirely possible that the shares could double again from here. After all, this was a $10 stock a year and a half ago. Could it get there again before the year is over?InvestorPlace – Stock Market News, Stock Advice & Trading Tips * 7 Hotel Stocks to Buy Before Vacationing Restarts When Flat Is All You Could Ask forBetween the havoc caused to automotive supply chains in China and the demand destruction in terms of new-vehicle sales, the novel coronavirus is quite possibly the worst thing that could have happened to Nio and its shareholders.All things considered, though, an argument could be made that the company is taking the Covid-19 mayhem in stride. Or at the very least, the damage control has been adequate.This is reflected in the price action of Nio stock, which is working its way back up to the 52-week high of about $6. Besides, there's a glimmer of hope on the horizon for the Chinese automotive market, and hence for Nio.As Baird analyst David Leiker points out, automotive production in China cratered by 44% during this year's first quarter. There was a bounce-back in April, however, as nationwide production was flat for that month on a year-over-year basis.Amid the backdrop of a viral pandemic, flat is pretty darned good. The airlines and the cruise-ship companies would gladly take flat over their current conditions. And China is still the world's largest electric-car market, so Nio's got a big, albeit weather-beaten, playground to play in. A Realistic ReboundWhen it comes to the automotive market, investors would be better off keeping their expectations low. If you're hoping for a tremendous rebound in the current market conditions, you're only setting yourself up for a major disappointment.Nio's first-quarter financial results paint a picture of a company in distress but starting to regain its footing. For instance, the company delivered 3,838 cars during that quarter. That's not too different from the 3,989 vehicles that Nio delivered during the same quarter of the previous year, long before the coronavirus craziness commenced.Moreover, the quarterly sales figure topped the analyst community's expectations. On average, they were projecting $180 million in quarterly sales for Nio. The actual result was roughly $194 million. So, add another one to the win column for Nio.Plus, we have to bear in mind the timeline of the coronavirus's spread in China, which peaked earlier than it did in the United States. China's financial struggles accelerated mainly during that first quarter. Against this backdrop, Nio's not-too-awful quarter was really quite impressive.And if we shift our scrutiny to April, which wasn't included in the first-quarter financial results, the overall picture really starts to brighten. Believe it or not, in April, Nio managed to deliver 3,155 vehicles. To give you some context on that figure, it's more than twice March's deliveries.It's also an improvement of more than 180% compared to Nio's deliveries in April of last year. Looking ahead now to the second quarter, Nio expects to deliver around 9,750 cars in that time frame.Summing up his evident relief, Nio CEO William Bin Li observed, "We have witnessed the order growth to have rebounded to the level prior to the Covid-19 outbreak since late April." The Takeaway on Nio StockAppreciating how "flat" can be really good isn't something that every investor's willing to do.If you're willing to take a data-backed leap of faith, however, then a long position in Nio stock could reward your tempered optimism in the long run.David Moadel has provided compelling content – and crossed the occasional line – on behalf of Crush the Street, Market Realist, TalkMarkets, Finom Group, Benzinga, and (of course) InvestorPlace.com. He also serves as the chief analyst and market researcher for Portfolio Wealth Global and hosts the popular financial YouTube channel Looking at the Markets. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * Why Everyone Is Investing in 5G All WRONG * Top Stock Picker Reveals His Next 1,000% Winner * The 1 Stock All Retirees Must Own * Look What America's Richest Family Is Investing in Now The post You Haven't (Yet) Missed the Nio Opportunity appeared first on InvestorPlace.

    from Yahoo Finance https://ift.tt/2BGv4l0

  • PFE | Pfizer and German partner BioNTech SE said Tuesday they’ve begun delivering doses of their coronavirus vaccine to US candidates with trials in Germany already underway.

  • PFE | Pfizer and German Parker BioNTech SE have begun delivering doses of their coronavirus vaccine for human testing US, trials in Germany already underway.

  • The performance outlook of tech companies.

  • Top broker urging you to buy this ASX 200 retail stock next week